Indication

Refractory malignant tumor of testis

A refractory malignant tumor of the testis refers to a cancerous neoplasm arising in the male gonadal tissue—most commonly a germ cell tumor such as a seminoma or nonseminomatous lesion—that demonstrates disease progression during treatment or recurs shortly following standard platinum-based chemotherapy regimens. Read more about Refractory malignant tumor of testis

22 drugs 21 manufacturers

Advertisement

Drugs that treat it

Common Refractory malignant tumor of testis therapies.

Showing 19–22 of 22 drugs

DACTINOMYCIN

DACTINOMYCIN·EWING'S SARCOMA·+4
MEITHEAL PHARMA

DACTINOMYCIN

DACTINOMYCIN·EWING'S SARCOMA·+4
AURO MEDICS PHA

ETOPOSIDE

ANTINEOPLASTIC - EPIPODOPHYLLOTOXINS·SMALL CELL LUNG CARCINOMA·+1
MEITHEAL PHARMA

AVOPEF (etoposide)

ANTINEOPLASTIC - EPIPODOPHYLLOTOXINS·SMALL CELL LUNG CARCINOMA·+1
AVYXA PHARMA, L
Filter & compare in the drug finder →Opens the drug finder with Refractory malignant tumor of testis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Refractory malignant tumor of testis.

A refractory malignant tumor of the testis refers to a cancerous neoplasm arising in the male gonadal tissue—most commonly a germ cell tumor such as a seminoma or nonseminomatous lesion—that demonstrates disease progression during treatment or recurs shortly following standard platinum-based chemotherapy regimens.

Primarily affecting adolescent and adult males, this clinical state represents a high-risk, treatment-resistant stage of testicular malignancy characterized by persistent tumor growth, escalating serum tumor markers such as alpha-fetoprotein or human chorionic gonadotropin, or the development of new metastatic lesions.

Pathophysiologically, the tumor cells have developed intrinsic or acquired resistance mechanisms—such as enhanced DNA damage repair, altered drug transport, or defective apoptotic signaling—rendering the disease unresponsive to standard frontline and conventional salvage therapeutic approaches.

Personalize your experience

Follow Refractory malignant tumor of testis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it